Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Monomorphic Epitheliotropic Intestinal T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-01Clinical Trial Update: Tazemetostat Plus CHOP in 1L T-cell Lymphoma [Phase 2]
A Phase 2 trial evaluating tazemetostat in combination with CHOP for first-line T-cell lymphomas has been withdrawn.